Literature DB >> 29988119

Expanded TCRβ CDR3 clonotypes distinguish Crohn's disease and ulcerative colitis patients.

J Wu1, A H Pendegraft2, M Byrne-Steele3, Q Yang3, C Wang3, W Pan3, T Lucious1, T Seay1, X Cui4, C O Elson1, J Han3, P J Mannon5.   

Abstract

We aimed to determine whether the TCR repertoires of Crohn's disease (CD) patients contain highly prevalent disease-specific T-cell clonotypes reflective of the characteristic and highly shared aberrant serum antibody reactivity to gut commensal flagellin antigens. The CD4 TCRβ CDR3 sequence repertoires from active CD (n = 20) and ulcerative colitis (UC) (n = 10) patients were significantly more diverse, and individual sequences over-represented, compared to healthy controls (HC) (n = 97). While a very small number of expanded public CDR3 sequences are highly shared between active CD and UC, the majority of significantly expanded TCRβ CDR3 clonotypes are private to CD and UC patients with equivalent prevalence among IBD patients. Further defining TCR clonotypes by Vβ-CDR3 linkage showed significant differences in the TCR repertoires between UC and CD. Flagellin antigen exposure induced expansion of several TCRβ CDR3 sequences in CD4 cells from a flagellin-seropositive subject including sequences highly shared by or relatively private to CD (and UC) patients. These data suggest that flagellin-reactivity contributes to the expansion of a small number of CD4 clonotypes but does not support flagellin antigens as predominantly driving CD4 cell proliferation in CD. Disease-specific expanded TCRβ CDR3 clonotypes characterize CD and UC and the shared exposure to the gamut of gut microbial antigens.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29988119     DOI: 10.1038/s41385-018-0046-z

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  7 in total

Review 1.  Pathway paradigms revealed from the genetics of inflammatory bowel disease.

Authors:  Daniel B Graham; Ramnik J Xavier
Journal:  Nature       Date:  2020-02-26       Impact factor: 49.962

2.  Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.

Authors:  Katie L Alexander; Qing Zhao; Meagan Reif; Alexander F Rosenberg; Peter J Mannon; Lennard Wayne Duck; Charles O Elson
Journal:  Gastroenterology       Date:  2021-05-07       Impact factor: 33.883

3.  OLGA: fast computation of generation probabilities of B- and T-cell receptor amino acid sequences and motifs.

Authors:  Zachary Sethna; Yuval Elhanati; Curtis G Callan; Aleksandra M Walczak; Thierry Mora
Journal:  Bioinformatics       Date:  2019-09-01       Impact factor: 6.937

Review 4.  Regulatory T-cell therapy in Crohn's disease: challenges and advances.

Authors:  Jennie N Clough; Omer S Omer; Scott Tasker; Graham M Lord; Peter M Irving
Journal:  Gut       Date:  2020-01-24       Impact factor: 23.059

5.  A novel unconventional T cell population enriched in Crohn's disease.

Authors:  Ilgar Z Mamedov; Petra Bacher; Andre Franke; Elisa Rosati; Gabriela Rios Martini; Mikhail V Pogorelyy; Anastasia A Minervina; Frauke Degenhardt; Mareike Wendorff; Soner Sari; Gabriele Mayr; Antonella Fazio; Christel Marie Dowds; Charlotte Hauser; Florian Tran; Witigo von Schönfels; Julius Pochhammer; Maria A Salnikova; Charlot Jaeckel; Johannes Boy Gigla; Sanaz Sedghpour Sabet; Matthias Hübenthal; Esther Schiminsky; Stefan Schreiber; Philip C Rosenstiel; Alexander Scheffold; Paul G Thomas; Wolfgang Lieb; Bernd Bokemeyer; Maria Witte; Konrad Aden; Alexander Hendricks; Clemens Schafmayer; Jan-Hendrick Egberts
Journal:  Gut       Date:  2022-03-09       Impact factor: 31.793

6.  High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis.

Authors:  Xiaolan Ye; Zhe Wang; Qiang Ye; Jing Zhang; Ping Huang; Jingying Song; Yiwen Li; Hongjuan Zhang; Feifeng Song; Zixue Xuan; Kejian Wang
Journal:  Front Immunol       Date:  2020-08-06       Impact factor: 7.561

7.  Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.

Authors:  Xuefeng Niu; Song Li; Pingchao Li; Wenjing Pan; Qian Wang; Ying Feng; Xiaoneng Mo; Qihong Yan; Xianmiao Ye; Jia Luo; Linbing Qu; Daniel Weber; Miranda L Byrne-Steele; Zhe Wang; Fengjia Yu; Fang Li; Richard M Myers; Michael T Lotze; Nanshan Zhong; Jian Han; Ling Chen
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.